Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Semaglutide for Sale > Semaglutide GLP-1 Peptide High Purity Research Grade White powder 99
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - large image1
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - image1
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - image2
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - image3
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - image4
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - image5
Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 buy - image6

Semaglutide GLP-1 Peptide High Purity Research Grade White powder 99

TDS 492 Inquiries

Unit Price:

$60/UNIT FOB

Get Latest Price
CAS No.:

910463-68-2

Grade:

Industrial Grade

Content:

99%

Port:

Hongkong

Brand:

Novio

Packaging:

10 bottles/box

Price valid (until):

2026-08-30

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Semaglutide Effects and Mechanism of Action
    Comprehensive Introduction of Semaglutide (CAS No. 910463-68-2)
    1. Overview of Semaglutide

    Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist and a synthetic peptide compound developed based on the structure of human GLP-1. It is a modified peptide molecule designed to provide enhanced stability and prolonged biological activity compared with native GLP-1.

    Semaglutide belongs to the peptide hormone analogue family and consists of 31 amino acids. It has been widely studied in metabolic research due to its interaction with the GLP-1 receptor signaling pathway. The compound is commonly used in scientific research related to glucose metabolism, insulin secretion regulation, appetite control mechanisms, and energy balance.

    Product Information:

    Product Name: Semaglutide
    CAS Number: 910463-68-2
    Molecular Formula: C187H291N45O59
    Molecular Weight: Approximately 4114 g/mol
    Product Type: Peptide / GLP-1 Analog
    Appearance: White Lyophilized Powder
    Purity: ≥98% (HPLC)
    Grade: Research Grade / Pharmaceutical Intermediate Grade

    Semaglutide has attracted significant attention in pharmaceutical research because of its unique molecular characteristics, high receptor selectivity, and long-lasting activity.

    2. Mechanism of Action of Semaglutide

    The primary biological target of Semaglutide is the GLP-1 receptor, a receptor belonging to the class B G protein-coupled receptor family.

    GLP-1 receptors are widely expressed in tissues associated with metabolic regulation, including pancreatic cells, gastrointestinal systems, and areas of the central nervous system involved in appetite regulation.

    When Semaglutide binds to the GLP-1 receptor, it activates downstream intracellular signaling pathways, including cyclic adenosine monophosphate (cAMP)-related pathways. This activation contributes to several physiological responses associated with glucose balance and energy regulation.

    The major mechanisms studied include:

    2.1 Regulation of Glucose Metabolism

    Semaglutide has been extensively researched for its ability to influence glucose metabolism through GLP-1 receptor activation.

    The GLP-1 signaling pathway plays an important role in glucose-dependent insulin secretion. Research indicates that GLP-1 receptor activation may enhance pancreatic beta-cell responses when glucose levels are elevated.

    Compared with short-acting GLP-1 molecules, Semaglutide demonstrates extended receptor activity due to structural modifications that improve resistance to enzymatic degradation.

    2.2 Enhancement of Insulin Secretion Response

    One of the important research areas involving Semaglutide is its relationship with pancreatic beta-cell function.

    GLP-1 receptor stimulation can support glucose-dependent insulin secretion, meaning insulin release is primarily enhanced when glucose concentrations are elevated.

    This glucose-dependent mechanism is an important characteristic of GLP-1 receptor agonists and has made Semaglutide a significant research compound in metabolic science.

    2.3 Regulation of Glucagon Secretion

    Glucagon is a hormone involved in increasing blood glucose availability.

    Research on GLP-1 receptor signaling suggests that activation of this pathway may influence pancreatic alpha-cell activity and contribute to regulation of glucagon secretion.

    Through modulation of insulin and glucagon signaling pathways, Semaglutide has become an important molecule for investigating glucose homeostasis.

    3. Semaglutide and Appetite Regulation Research

    A major research interest surrounding Semaglutide is its relationship with appetite and energy balance.

    GLP-1 receptors are expressed in areas of the brain involved in appetite regulation. Semaglutide signaling has been investigated for its potential effects on:

    Appetite-related pathways
    Food intake regulation
    Satiety signaling
    Energy balance mechanisms

    Research suggests that GLP-1 receptor activation may influence communication between peripheral metabolic signals and the central nervous system.

    This makes Semaglutide an important research tool for studying the biological mechanisms involved in appetite control and metabolic regulation.

    4. Research on Weight Management Mechanisms

    Semaglutide has become one of the most widely studied peptide compounds in obesity and metabolic research.

    Body weight regulation involves multiple biological systems, including:

    Energy intake
    Energy expenditure
    Hormonal signaling
    Gastrointestinal function
    Central nervous system pathways

    Semaglutide research focuses on how GLP-1 receptor activation may affect these interconnected processes.

    Potential research areas include:

    Appetite Signaling

    Semaglutide has been investigated for its influence on appetite-related neural pathways and satiety signals.

    Energy Balance

    Researchers study the relationship between GLP-1 signaling and overall energy homeostasis.

    Metabolic Adaptation

    Semaglutide provides a valuable research model for understanding hormonal regulation of metabolism.

    5. Gastrointestinal Research Applications

    GLP-1 signaling is closely associated with gastrointestinal physiology.

    Semaglutide research has examined its relationship with:

    Gastric emptying regulation
    Digestive system signaling
    Nutrient sensing mechanisms

    The interaction between GLP-1 receptors and gastrointestinal pathways represents an important field in metabolic science.

    6. Semaglutide in Diabetes Research

    Semaglutide has been extensively researched in the field of diabetes and glucose metabolism.

    Diabetes research focuses on understanding:

    Insulin signaling pathways
    Pancreatic beta-cell function
    Glucose homeostasis
    Hormonal regulation mechanisms

    As a GLP-1 receptor agonist analogue, Semaglutide serves as an important molecular tool for investigating these biological processes.

    Researchers continue studying GLP-1-based compounds to better understand metabolic regulation and potential therapeutic applications.

    7. Molecular Characteristics and Stability

    Semaglutide has been structurally modified from native GLP-1 to improve molecular stability.

    Important molecular characteristics include:

    Long-Acting Peptide Structure

    The molecular design of Semaglutide allows prolonged interaction with GLP-1 receptors compared with natural GLP-1.

    Improved Enzyme Resistance

    Structural modifications contribute to increased resistance against enzymatic breakdown.

    High Molecular Specificity

    Semaglutide demonstrates selective interaction with GLP-1 receptor pathways, making it valuable for biochemical research.

    8. Laboratory Research Applications

    Semaglutide is widely used in peptide and metabolic research laboratories.

    Common research applications include:

    Metabolic Pathway Studies

    Used as a research compound for investigating hormone-related metabolic signaling.

    GLP-1 Receptor Research

    Supports studies related to receptor activation and intracellular signaling.

    Peptide Biology Research

    Used in investigations involving peptide structure, activity, and stability.

    Drug Discovery Research

    Provides a reference compound for developing and evaluating new peptide-based molecules.

    9. Advantages of Semaglutide Research Compound

    Semaglutide offers several characteristics that make it attractive for scientific research:

    High Biological Relevance

    Semaglutide is based on a naturally occurring human peptide hormone pathway.

    Strong Research Interest

    The compound has become a major focus in metabolic and peptide science.

    Advanced Peptide Technology

    Its molecular structure represents modern peptide engineering approaches.

    Analytical Compatibility

    Semaglutide can be characterized using advanced analytical techniques, including:

    HPLC analysis
    Mass spectrometry
    Peptide identification methods
    10. Quality Characteristics of Semaglutide

    High-quality Semaglutide research materials are generally characterized by:

    High purity profile
    Accurate molecular identification
    Consistent batch quality
    Stable lyophilized formulation
    Professional packaging

    Typical analytical evaluation methods include:

    HPLC Purity Testing

    Used to evaluate chemical purity.

    Mass Spectrometry

    Used for molecular weight confirmation.

    Appearance Inspection

    Used to verify physical characteristics.

    11. Storage and Handling Information

    Semaglutide peptide products are commonly supplied as lyophilized powders.

    Recommended storage conditions:

    Temperature: -20°C recommended
    Protect from moisture
    Avoid repeated temperature fluctuations
    Store in sealed containers

    Proper storage helps maintain peptide stability and quality during research applications.

    12. Future Research Potential

    The discovery and development of GLP-1 receptor-based molecules have significantly expanded understanding of metabolic regulation.

    Future research directions involving Semaglutide may include:

    Advanced metabolic pathway studies
    Combination peptide research
    Next-generation GLP-1 analogue development
    Peptide engineering technologies
    Hormonal regulation research

    As peptide science continues to advance, Semaglutide remains an important reference molecule in the study of metabolic biology.

    Conclusion

    Semaglutide is a highly studied GLP-1 receptor agonist peptide compound with significant importance in metabolic research. Through interaction with GLP-1 receptor pathways, Semaglutide provides researchers with valuable opportunities to investigate glucose regulation, insulin signaling, appetite mechanisms, energy balance, and peptide-based therapeutic strategies.

    With its well-characterized molecular structure, high research interest, and broad application potential, Semaglutide continues to serve as an important compound in peptide science, biotechnology research, and pharmaceutical development.

    Semaglutide CAS 910463-68-2 represents an advanced peptide research material suitable for laboratories, biotechnology companies, and pharmaceutical research organizations focusing on metabolic pathways and GLP-1 related studies.
    Items Specifications
    Official Name Semaglutide
    CAS Number 910463-68-2
    Molecular Formula C187H291N45O59Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 1

    Shop Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99-Detailed Image 2

    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 3
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 4
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 5
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 6
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 7
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 8
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 9
    Shop Semaglutide CAS 910463-68-2 GLP-1 Peptide High Purity Research Grade-Detailed Image 10
    ECHEMI Editorial Reference

    Semaglutide (CAS: 910463‑68‑2) is a synthetic lipid‑modified peptide analogue, consisting of a 31‑amino‑acid backbone with a covalently attached C18 fatty di‑acid side‑chain via a hydrophilic spacer. It shares 94% amino‑acid sequence homology with native human GLP‑1 peptide. The substance appears as white to almost white hygroscopic powder, with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of 4113.58 g/mol. Structural modifications grant it resistance against DPP‑4 enzymatic degradation and enable reversible binding to serum albumin, contributing to its extended in‑vivo half‑life property.

    Certificates
    • Semaglutide  GLP-1 Peptide High Purity Research Grade White powder 99 Certificates 1 TDS

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide Injection

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    EC Number:

    203-405-2

    Color/Form:

    White to off-white

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

    Location:

    Room 1359, Room 103, Building Jia 19, Jixiang Garden, Tongzhou District, Beijing

    Year of Establishment:

    2026

  • Inquiry History
    492 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Weight Loss Semaglutide intermediate 99% White powder COA High Quality peptide GLP-1 910463-68-2

    5 MG Apr 11, 2024
    United States

    Gene-Biocon Semaglutide 910463-68-2 GLP-1analogs diabetes weight loss 96% White or off-white powder

    Dec 5, 2023
    United States

    Semaglutide 910463-68-2

    1 G Sep 21, 2023
    United States

    Sermaglutide 99% 910463-68-2

    2 KG Oct 21, 2023
    China

    Semaglutide CAS 910463-68-2

    1 KG Apr 16, 2026
    United Kingdom

    TGYFactory Supply Semaglutide Peptide 99% CAS 910463-68-2

    50 MT Nov 13, 2023
    Sri Lanka

    Bulk Supply 98% up Sermaglutide powder CAS 910463-68-2

    300 G Nov 18, 2023
    United States

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    500 G Oct 9, 2023
    United States

    Raw mateiral Semaglutide CAS 910463-68-2 99% White powder

    1000 G Sep 23, 2023
    Switzerland

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    5000 MT Sep 13, 2023
    United States

    High Purity Peptide Semaglutide 910463-68-2 With Safe Shipping

    1 G Sep 7, 2023
    United States

    10MG vial pack Semaglutide 99% 910463-68-2 GLP-1 Peptide

    10 MT Oct 18, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    60 MG Aug 4, 2025
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10 MT Sep 19, 2025
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    Nov 13, 2024
    United States

    semaglutide CAS 910463-68-2 in stock 2-4 days safe delivery

    1 MT Nov 4, 2023
    United Kingdom

    API Pharmaceutical Chemical Grade Raw Materials CAS 910463-68-2 Semaglutide

    40 MT Sep 27, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10  Sep 27, 2023
    China

    Semaglutide Tirzepatide for Weight Loss CAS: 910463-68-2 Retatrutide Cagrilintide

    1 MT Jul 5, 2025
    India

    Best Price 99% Semaglutide Peptide 10mg Vials Semaglutide CAS 910463-68-2

    100  Nov 8, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.